Redmile Group as of Dec. 31, 2019
Portfolio Holdings for Redmile Group
Redmile Group holds 64 positions in its portfolio as reported in the December 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Deciphera Pharmaceuticals (DCPH) | 7.0 | $293M | 4.7M | 62.24 | |
Allakos (ALLK) | 6.9 | $289M | 3.0M | 95.36 | |
Amicus Therapeutics (FOLD) | 5.9 | $246M | 25M | 9.74 | |
Fate Therapeutics (FATE) | 5.2 | $220M | 11M | 19.57 | |
Epizyme | 5.2 | $215M | 8.7M | 24.60 | |
Argenx Se (ARGX) | 4.4 | $185M | 1.2M | 160.52 | |
Uniqure Nv (QURE) | 4.4 | $183M | 2.6M | 71.66 | |
Principia Biopharma | 3.6 | $149M | 2.7M | 54.78 | |
Biogen Idec (BIIB) | 3.2 | $136M | 458k | 296.73 | |
Igm Biosciences (IGMS) | 2.9 | $120M | 3.1M | 38.16 | |
Bristol Myers Squibb (BMY) | 2.8 | $116M | 1.8M | 64.19 | |
Nevro (NVRO) | 2.6 | $110M | 939k | 117.54 | |
Forty Seven | 2.6 | $109M | 2.8M | 39.37 | |
Aprea Therapeutics | 2.5 | $104M | 2.3M | 45.89 | |
Regenxbio Inc equity us cm (RGNX) | 2.5 | $103M | 2.5M | 40.97 | |
Centene Corporation (CNC) | 2.3 | $98M | 1.6M | 62.87 | |
Tricida | 1.9 | $80M | 2.1M | 37.74 | |
Atara Biotherapeutics (ATRA) | 1.8 | $77M | 4.6M | 16.47 | |
ImmunoGen | 1.8 | $75M | 15M | 5.11 | |
Boston Scientific Corporation (BSX) | 1.8 | $74M | 1.6M | 45.22 | |
Tandem Diabetes Care (TNDM) | 1.7 | $70M | 1.2M | 59.61 | |
Momenta Pharmaceuticals | 1.5 | $64M | 3.2M | 19.73 | |
Krystal Biotech (KRYS) | 1.4 | $60M | 1.1M | 55.38 | |
UnitedHealth (UNH) | 1.4 | $60M | 203k | 293.98 | |
Novartis (NVS) | 1.3 | $54M | 573k | 94.69 | |
Pra Health Sciences | 1.2 | $50M | 450k | 111.15 | |
Axonics Modulation Technolog (AXNX) | 1.0 | $43M | 1.5M | 27.71 | |
Hca Holdings (HCA) | 1.0 | $42M | 285k | 147.81 | |
Ptc Therapeutics I (PTCT) | 1.0 | $41M | 860k | 48.03 | |
Eidos Therapeutics | 1.0 | $40M | 701k | 57.39 | |
Replimune Group (REPL) | 0.9 | $40M | 2.8M | 14.35 | |
Scholar Rock Hldg Corp (SRRK) | 0.9 | $39M | 2.9M | 13.18 | |
Audentes Therapeutics | 0.9 | $38M | 639k | 59.84 | |
Anthem (ELV) | 0.7 | $30M | 101k | 302.03 | |
Guardant Health (GH) | 0.7 | $31M | 390k | 78.14 | |
Amedisys (AMED) | 0.7 | $30M | 181k | 166.92 | |
Ardelyx (ARDX) | 0.7 | $30M | 4.0M | 7.50 | |
Cigna Corp (CI) | 0.7 | $30M | 148k | 204.49 | |
Stoke Therapeutics (STOK) | 0.7 | $29M | 1.0M | 28.32 | |
Gritstone Oncology Ord (GRTS) | 0.7 | $28M | 3.1M | 8.97 | |
Wave Life Sciences (WVE) | 0.6 | $27M | 3.3M | 8.02 | |
Akero Therapeutics (AKRO) | 0.6 | $26M | 1.2M | 22.19 | |
Odonate Therapeutics Ord | 0.6 | $26M | 790k | 32.45 | |
Tcr2 Therapeutics Inc cs | 0.6 | $26M | 1.8M | 14.28 | |
Shockwave Med (SWAV) | 0.6 | $25M | 568k | 43.92 | |
Neoleukin Therapeutics | 0.6 | $24M | 1.9M | 12.32 | |
Hookipa Pharma Inc equity (HOOK) | 0.6 | $23M | 1.9M | 12.23 | |
Xeris Pharmaceuticals | 0.5 | $21M | 3.0M | 7.05 | |
Genmab A/s -sp (GMAB) | 0.5 | $21M | 937k | 22.33 | |
Cabaletta Bio (CABA) | 0.5 | $20M | 1.4M | 13.97 | |
Atreca Inc Cl A (BCEL) | 0.4 | $18M | 1.1M | 15.47 | |
Stereotaxis (STXS) | 0.4 | $17M | 3.2M | 5.29 | |
G1 Therapeutics (GTHX) | 0.4 | $16M | 614k | 26.43 | |
Cryoport Inc Com Par $0 001 (CYRX) | 0.3 | $14M | 842k | 16.46 | |
Adaptive Biotechnologies Cor (ADPT) | 0.3 | $13M | 426k | 29.92 | |
Vapotherm | 0.3 | $12M | 960k | 12.16 | |
Glycomimetics (GLYC) | 0.2 | $7.1M | 1.3M | 5.29 | |
Biontech Se (BNTX) | 0.1 | $5.9M | 174k | 33.88 | |
Cymabay Therapeutics | 0.1 | $5.5M | 2.8M | 1.96 | |
Gossamer Bio (GOSS) | 0.1 | $4.1M | 260k | 15.63 | |
Syros Pharmaceuticals | 0.0 | $1.5M | 212k | 6.91 | |
Ovid Therapeutics (OVID) | 0.0 | $506k | 122k | 4.15 | |
Castlight Health | 0.0 | $14k | 10k | 1.37 | |
Endologix | 0.0 | $124k | 79k | 1.57 |